Evidence map›Paper›PMID 39134233›Full record

ArticleJournal of biomedical informatics2024

Balancing the efforts of chart review and gains in PRS prediction accuracy: An empirical study.

Yuqing Lei, Adam Christian Naj, Hua Xu, Ruowang Li, Yong Chen

Abstract read
In one paragraph

Article in Journal of biomedical informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuqing LeiDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.
Adam Christian NajDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA; Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.
Hua XuDepartment for Biomedical Informatics and Data Science, Yale School of Medicine, Yale University, New Haven, CT, USA.
Ruowang LiDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: Ruowang.Li@cshs.org.
Yong ChenDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA. Electronic address: ychen123@upenn.edu.

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
Coordinating Individually Measured Phenotypes to Advance Mental Health ResearchU24MH136069 · NIMH · YALE UNIVERSITY · PI Yong Chen, Cui Tao · 2024 to 2026
$9.8M
Genome Wide associate analysis of Alzheimer's DiseaseRC2AG036528 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2010
$5.4M
PANDA-MSD: Predictive Analytics via Networked Distributed Algorithms for Multi-System DiseasesU01TR003709 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI BIAN, JIANG, CHEN, YONG · 2022 to 2025
$4.7M
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting biasR01AG073435 · NIA · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, XU, HUA · 2021 to 2025
$3.9M
Dynamic learning for post-vaccine event prediction using temporal information in VAERSR01AI130460 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHEN, YONG, TAO, CUI · 2017 to 2021
$3.4M
ClinEX - Clinical Evidence Extraction, Representation, and AppraisalR01LM014344 · NLM · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Yong Chen, Yifan Peng · 2023 to 2026
$2.7M
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methodsRF1AG077820 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BIAN, JIANG, CHEN, YONG · 2023 to 2023
$2.3M
PheBC: bias correction methods for EHR derived phenotypeR01LM013519 · NLM · UNIVERSITY OF PENNSYLVANIA · PI CHEN, YONG, XU, HUA · 2021 to 2024
$1.6M
Advancing Drug Repositioning for Alzheimer’s Disease using Real-world DataR56AG069880 · NIA · UNIVERSITY OF FLORIDA · PI BIAN, JIANG, CHEN, YONG · 2021 to 2022
$1.6M
NCATS NIH HHS U01 TR003709NEI NIH HHS R21 EY034179NIAID NIH HHS R01 AI130460NIAID NIH HHS R21 AI167418NIA NIH HHS R01 AG073435NIA NIH HHS R56 AG069880NIA NIH HHS R56 AG074604NIA NIH HHS RC2 AG036528NIA NIH HHS RF1 AG077820NIA NIH HHS U01 AG016976NIA NIH HHS U01 AG032984NIA NIH HHS U24 AG021886NIMH NIH HHS U24 MH136069NLM NIH HHS R01 LM012607NLM NIH HHS R01 LM013519NLM NIH HHS R01 LM014344
6 · The paper itself

Abstract

objectivePhenotypic misclassification in genetic association analyses can impact the accuracy of PRS-based prediction models. The bias reduction method proposed by Tong et al. (2019) has demonstrated its efficacy in reducing the effects of bias on the estimation of association parameters between genotype and phenotype while minimizing variance by employing chart reviews on a subset of the data for validating phenotypes, however its improvement of subsequent PRS prediction accuracy remains unclear. Our study aims to fill this gap by assessing the performance of simulated PRS models and estimating the optimal number of chart reviews needed for validation.

methodsTo comprehensively assess the efficacy of the bias reduction method proposed by Tong et al. in enhancing the accuracy of PRS-based prediction models, we simulated each phenotype under different correlation structures (an independent model, a weakly correlated model, a strongly correlated model) and introduced error-prone phenotypes using two distinct error mechanisms (differential and non-differential phenotyping errors). To facilitate this, we used genotype and phenotype data from 12 case-control datasets in the Alzheimer's Disease Genetics Consortium (ADGC) to produce simulated phenotypes. The evaluation included analyses across various misclassification rates of original phenotypes as well as quantities of validation set. Additionally, we determined the median threshold, identifying the minimal validation size required for a meaningful improvement in the accuracy of PRS-based predictions across a broad spectrum.

resultsThis simulation study demonstrated that incorporating chart review does not universally guarantee enhanced performance of PRS-based prediction models. Specifically, in scenarios with minimal misclassification rates and limited validation sizes, PRS models utilizing debiased regression coefficients demonstrated inferior predictive capabilities compared to models using error-prone phenotypes. Put differently, the effectiveness of the bias reduction method is contingent upon the misclassification rates of phenotypes and the size of the validation set employed during chart reviews. Notably, when dealing with datasets featuring higher misclassification rates, the advantages of utilizing this bias reduction method become more evident, requiring a smaller validation set to achieve better performance.

conclusionThis study highlights the importance of choosing an appropriate validation set size to balance between the efforts of chart review and the gain in PRS prediction accuracy. Consequently, our study establishes a valuable guidance for validation planning, across a diverse array of sensitivity and specificity combinations.

Indexed as

Alzheimer DiseasePhenotypeCase-Control StudiesComputer SimulationGenetic Association StudiesGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansModels, GeneticPolymorphism, Single NucleotideChart ReviewMisclassificationPhenotyping ErrorPolygenetic Risk Score

Identifiers

PMID39134233
PMCPMC12235752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.